XML 34 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities    
Net incomre (loss) $ 267 $ 9,947
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on abandonment of property and equipment 0 44
Gain on sale of Reconstructive and Spine Divisions 0 (11,842)
Allowance for doubtful accounts 0 175
Stock option compensation 5 31
Changes in operating assets and liabilities:    
Accounts receivable 43 98
Inventories 0 85
Due from Arthrex 0 (22)
Income tax receivable (532) 0
Prepaid expenses and other current assets 77 87
Other assets 0 31
Accounts payable and accrued expenses (615) (912)
Net cash used in operating activities (755) (2,278)
Cash flows from investing activities    
Purchases of property and equipment 0 (137)
Decrease (increase) in restricted cash 900 (1,219)
Proceeds from sale of Reconstructive and Spine Divisions 0 16,615
Net cash provided by investing activities 900 15,259
Cash flows from financing activities    
Proceeds from notes payable 0 1,224
Payments of notes payable 0 (1,724)
Net cash used in financing activities 0 (500)
Net change in cash 145 12,481
Cash, beginning of period 12,678 127
Cash, end of period 12,823 12,608
Supplemental disclosure of cash flow information:    
Interest paid 0 25
Income taxes paid $ 553 $ 0